The MATISSE study: a randomised trial of group art therapy for people with schizophrenia
Authors:
- Mike J CrawfordMCMike J Crawford
- Helen KillaspyHKHelen Killaspy
- Eleftheria KalaitzakiEKEleftheria Kalaitzaki
- Barbara BarrettBBBarbara Barrett
- Sarah ByfordSBSarah Byford
- Sue PattersonSPSue Patterson
- Tony SoteriouTSTony Soteriou
- Francis A O'NeillFOFrancis A O'Neill
- Katie ClaytonKCKatie Clayton
- Anna MaratosAMAnna Maratos
- Thomas R BarnesTBThomas R Barnes
- David OsbornDODavid Osborn
Open Access
- 27 August 2010
- journal article
- research article
- Published by Springer Nature in BMC Psychiatry
- Vol. 10 (1) , 65
Abstract
Art Therapy has been promoted as a means of helping people who may find it difficult to express themselves verbally engage in psychological treatment. Group Art Therapy has been widely used as an adjunctive treatment for people with schizophrenia but there have been few attempts to examine its effects and cost effectiveness has not been examined. The MATISSE study aims to evaluate the clinical and cost effectiveness of group Art Therapy for people with schizophrenia. The MATISSE study is a three-arm, parallel group, pragmatic, randomised, controlled trial of referral to group Art Therapy plus standard care, referral to an attention control 'activity' group plus standard care, or standard care alone. Study participants were recruited from inpatient and community-based mental health and social care services at four centres in England and Northern Ireland. Participants were aged over 18 years with a clinical diagnosis of schizophrenia, confirmed by an examination of case notes using operationalised criteria. Participants were then randomised via an independent and remote telephone randomisation service using permuted stacked blocks, stratified by site. Art Therapy and activity groups were made available to participants once a week for up to 12 months. Outcome measures were assessed by researchers masked to allocation status at 12 and 24 months after randomisation. Participants and care givers were aware which arm of the trial participants were allocated to. The primary outcomes for the study are global functioning (measured using the Global Assessment of Functioning scale) and mental health symptoms (measured using the Positive and Negative Syndrome Scale) assessed at 24 months. Secondary outcomes were assessed at 12 and 24 months and comprise levels of group attendance, social function, satisfaction with care, mental wellbeing, and costs. We believe that this is the first large scale pragmatic trial of Art Therapy for people with schizophrenia. Current Controlled Trials ISRCTN46150447Keywords
This publication has 39 references indexed in Scilit:
- The great divide: A qualitative investigation of factors influencing researcher access to potential randomised controlled trial participants in mental health settingsJournal of Mental Health, 2010
- Developing and evaluating complex interventions: the new Medical Research Council guidanceBMJ, 2008
- Exploratory RCT of art therapy as an adjunctive treatment in schizophreniaJournal of Mental Health, 2007
- Music therapy for in-patients with schizophreniaThe British Journal of Psychiatry, 2006
- Efficacy of Psychological Therapy in Schizophrenia: Conclusions From Meta-analysesSchizophrenia Bulletin, 2006
- Art therapy for schizophrenia or schizophrenia-like illnessesCochrane Database of Systematic Reviews, 2005
- Adjusting for partially missing baseline measurements in randomized trialsStatistics in Medicine, 2004
- Frequency and predictors of adverse eventsThe British Journal of Psychiatry, 1998
- UNINTEGRATION AND CONTAINMENT IN ACUTE PSYCHOSISBritish Journal of Psychotherapy, 1996
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994